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Abstract 
We have been using histological and electrophysiological techniques to compare the pathology and 
pathophysiology in different forms of experimental allergic encephalomyelitis (EAE) in the Lewis rat. In 
acute EAE induced by sensitization to myelin basic protein (MBP) or by the passive transfer of MBP-
specific lymphocytes, there is inflammation and demyelination in the ventral and dorsal spinal roots and 
inflammation and limited demyelination in the spinal cord. More extensive spinal cord demyelination as 
well as demyelination in the spinal roots and ganglia is observed in acute EAE induced by inoculation with 
whole central nervous system (CNS) tissue. In chronic relapsing EAE induced by inoculation with whole 
CNS tissue and treatment with low dose cyclosporin A, large plaques of spinal cord demyelination occur in 
rats with clinical episodes >28 days after inoculation. In rats with clinical disease <25 days after inoculation 
there is prominent demyelination in the spinal roots and ganglia as well as in the spinal cord. In all 4 forms 
of EAE, peripheral nervous system (PNS) remyelination by Schwann cells and CNS remyelination by 
oligodendrocytes occurs during clinical recovery. Electrophysiological studies revealed PNS and CNS 
nerve conduction abnormalities during clinical episodes, with improvement during remissions. 
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Introduction 
Experimental allergic encephalomyelitis (EAE) is an autoimmune T-cell-mediated 
demyelinating disease. It can be induced by active sensitization to whole central nervous 
system (CNS) tissue, purified myelin basic protein (MBP) or myelin proteolipid protein 
(PLP), or by the passive transfer of MBP-specific or PLP-specific lymphocytes. It may have 
either an acute or a chronic relapsing course. Acute EAE is a mono phasic disease and closely 
resembles the human demyelinating disease, acute disseminated encephalomyelitis; chronic 
relapsing EAE has many similarities with the human disease, multiple sclerosis. 
In this study we have used histological and electrophysiological techniques to compare the 
pathology and pathophysiology of different forms of EAE in the Lewis rat. 
 
Materials and Methods 
 
Animals 
Lewis rats (JC strain) were kept in cages of five and were fed rat and mouse cubes and water 
ad libitum. 
 
Induction of EAE 
Four different forms of EAE were induced. 
 
Myelin basic protein (MBP)-induced acute EAE (actively induced acute MBP-EAE) 
MBP was prepared from guinea pig spinal cord (after removal of the spinal roots) by the 
method of Deibler et al [1]. MBP in 0.9% saline was emulsified in an equal volume of 
incomplete Freund's adjuvant containing 4mg/ml of added Mycobacterium butyricum. Male 
rats, 8-10 weeks old, were inoculated with 0.l ml of emulsion in one footpad of each hindfoot. 
The total dose of MBP was 50 µg/rat. 
Passively transferred acute MBP-EAE 
Passive EAE was induced as previously described [14] Single-cell suspensions were prepared 
from the spleens of donor rats sensitized 10-12 days previously with MBP as described above. 
Cells were cultured at a concentration of 2 x 106 cells/ml in RPMI 1640 with added 5% fetal 
calf serum, 5 x 10-5 M 2-mercapto-ethanol, 200mM L-glutamine, penicillin and streptomycin. 
Concanavalin A was added at 2µg/ml, and 50m1 cultures were incubated at 37°C in an 
atmosphere of CO2 (10%), 02 (7%) and N2. Cells were harvested after 72h and washed with 
Hanks' balanced salt solution. 5 x 107 viable cells were injected into a lateral tail vein of each 
recipient male rat. 
 
Whole-spinal-cord-induced acute EAE 
 The inoculum was an homogenate of equal volumes of a 30% suspension of guinea pig 
spinal cord (the spinal roots having been removed) in 0.9% saline and a suspension of 4mg of 
killed and dried Mycobacterium butyricum (Difco) per ml of incomplete Freund's adjuvant 
(Commonwealth Serum Laboratories, Melbourne, Australia). Under anaesthesia, male rats 8-
10 weeks old were given 0.05ml of inoculum in the footpad of each of the four feet or 0.l ml 
in one footpad of each hindfoot. 
 
Chronic relapsing EAE 
Chronic relapsing EAE was induced as previously described [15]. Each batch of inoculum 
was prepared by homogenizing a mixture of 1g guinea pig spinal cord, l ml 0.9% saline, l ml 
complete Freund's adjuvant (Difco) and 10mg Mycobacterium tuberculosis H37RA (Difco). 
Female rats, 7-10 weeks old, were inoculated by the intradermal injection of 0.05m1 
inoculum into the medial footpad of the right hindfoot. Commencing on the day of 
inoculation, the rats were given subcutaneous injections of cyclosporin A (Sandoz; 4mg/kg) 
on alternate days until 22 days post-inoculation inclusive. 
 
Histological studies 
Under anaesthesia rats were perfused through the left ventricle with 0.9% saline followed by 
2.5% glutaraldehyde/2% formaldehyde in 0.1M sodium cacodylate buffer (pH 7.3-7.4). After 
removal, the spinal cord was immersed in fixative and postfixed with 1% osmium tetroxide 
(Dalton's solution), embedded in HistoResin (LKB, Bromma, Sweden) or Epox 812 (Ernest F 
Fullam, Schenectady, NY), sectioned (lµm) and stained with cresyl fast violet or toluidine 
blue respectively. Ultrathin Epox 812 sections were double-stained with uranyl acetate and 
lead citrate and examined with an Hitachi H-300 electron microscope. 
 
Electrophysiological studies 
These methods have been described in detail previously [7,9,13,17] Under anaesthesia, the 
left sciatic nerve was exposed in the posterior thigh and a lumbosacral laminectomy was 
performed. In some animals a right craniectomy was also performed. Nerve conduction in the 
peripheral nervous system (PNS) and in the central nervous system (CNS) was studied by 
direct stimulation of, and recording from, the exposed nervous tissues. 
 
Results 
 
Actively induced acute MBP-EAE 
Distal tail weakness commenced 8-13 days after inoculation and was followed by flaccid tail 
paralysis, hindlimb weakness and sometimes hindlimb paralysis. Clinical recovery occurred 
rapidly and by 18 days after inoculation there was only mild tail weakness. Histological 
studies revealed inflammation and limited demyelination in the spinal cord [10] The CNS 
parts of the dorsal root entry and ventral root exit zones were sites of predilection for 
demyelination. In the PNS there was perivascular mononuclear infiltration and demyelination 
in the lumbar, sacral and coccygeal ventral and dorsal roots [10,11] The dorsal root ganglia 
were mildly affected and the spinal and peripheral nerves showed no or minimal involvement. 
Electrophysiological studies revealed conduction block in the dorsal roots [7], reduced 
conduction velocities between the lumbar ventral roots and sciatic nerve, conduction block in 
a small proportion of fibres at the lumbar ventral root exit zones of the spinal cord and a 
markedly reduced H reflex [10]. These nerve conduction abnormalities could be explained by 
demyelination-induced conduction block in the PNS and CNS. During clinical recovery there 
was restoration of the H reflex and ensheathment and remyelination of the PNS by Schwann 
cells and of the CNS by oligodendrocytes[12]. 
 
Passively transferred acute MBP-EAE 
The clinical course was similar to that in rats with actively induced acute MBP-EAE except 
that the neurological signs commenced and resolved 6 days earlier. The neuropathological 
findings were similar to those in rats with actively induced acute MBP-EAE. There was 
inflammation and demyelination in the dorsal and ventral spinal roots and inflammation and 
limited demyelination in the spinal cord [14]. Demyelination in the spinal cord was 
concentrated in the dorsal root entry and ventral root exit zones. During clinical recovery 
there was ensheathment and remyelination of the PNS by Schwann cells and of the CNS by 
oligodendrocytes [14]. Formation of new compact myelin lamellae by Schwann cells was first 
observed 9 days after passive transfer (5 days after the onset of tail weakness) and by 
oligodendrocytes 10 days after passive transfer. 
 
Whole-spinal-cord-induced acute EAE 
The clinical course was similar to that in rats with actively induced acute MBP-EAE except 
that the neurological signs lasted longer. Histological studies showed more demyelination in 
the spinal cord than in rats with acute MBP-EAE [13]. The spinal cord demyelination was 
more extensive caudally than rostrally, and the CNS parts of the dorsal root entry and ventral 
root exit zones were sites of predilection. In the PNS there was inflammation and 
demyelination in the dorsal and ventral roots and particularly in the sacro-coccygeal dorsal 
root ganglia. There was minimal if any involvement of the spinal nerves and peripheral 
nerves. Electro-physiological studies revealed nerve conduction abnormalities in the regions 
of the dorsal root ganglia [13], conduction block at- the lumbar ventral root exit zones of the 
spinal cord and reduction of the H reflex [6,9] During clinical recovery there was evidence of 
restoration of nerve conduction and remyelination of the PNS by Schwann cells and of the 
CNS by oligodendrocytes [12]. 
 
Chronic relapsing EAE 
Rats inoculated with whole spinal cord tissue and adjuvants and treated with low dose 
cyclosporin A had a chronic relapsing or chronic progressive clinical course. Histological 
studies during the early stages of clinically active disease (<25 days after inoculation) 
revealed inflammation and primary demyelination in the CNS, particularly the spinal cord, 
and in the PNS, specifically the dorsal and ventral roots and dorsal root ganglia [15]. Animals 
studied in the later stages of clinically active disease (>28 days after inoculation) had 
extensive spinal cord demyelination but minimal PNS demyelination. In these animals, large 
plaques of demyelination with gliosis and prominent plasma cells occurred particularly in the 
thoracic spinal cord, and lesions of different ages were present within the spinal cord. CNS 
and PNS remyelination by oligodendrocytes and Schwann cells, respectively, was present in 
all animals studies later than 18 days after inoculation (the time of the first remission, if it 
occurred). Axonal degeneration was observed in the spinal cord and in the PNS. During 
clinical remission there was CNS and PNS remyelination and much less inflammation. 
Electrophysiological studies revealed conduction failure in both the CNS and PNS during the 
early and later stages of chronic relapsing EAE [17] Conduction was restored in some CNS 
and PNS fibres during remission but conduction abnormalities persisted in animals that were 
in late remission and that had no neurological signs. The reversible conduction abnormalities 
were explained by demyelination followed by remyelination in the CNS and PNS. The 
persistent conduction failure in late remission was mainly due to axonal degeneration. 
 
Table 
Extent of Demyelination in Different Forms of EAE 
Demyelination 
PNS CNS 
Active MBP-induced acute EAE       +       +− 
Passive MBP-induced acute EAE       +       +− 
Whole-spinal-cord-induced acute EAE      +       + 
Chronic relapsing EAE – early      +       ++ 
Chronic relapsing EAE – late      −       +++ 
 
Discussion 
 
The present studies demonstrate that demyelination is present in the CNS and proximal PNS 
(spinal roots and ganglia) in 4 different forms of EAE in the Lewis rat. The extent of 
demyelination varies with the form of EAE and the stage of the disease process (Table). In 
acute MBP-EAE, either actively induced or passively transferred, there is limited CNS 
demyelination. However, this CNS demyelination together with the PNS demyelination in the 
ventral and dorsal roots is likely to be an important cause of neurological signs in acute MBP-
EAE, as in the other types of EAE studied [8]. More extensive CNS demyelination occurs in 
[2] acute EAE induced by inoculation with whole CNS tissue than in acute MBP-EAE 
indicating that sensitization to additional myelin antigens is necessary to produce extensive 
CNS demyelination in Lewis rats. In the guinea pig the addition of galactocerebroside or total 
myelin lipids to MBP in the inoculum augments CNS demyelination [16] Furthermore, the 
administration of an antibody against myelin oligodendrocyte glycoprotein augments CNS 
demyelination in Lewis rats with passively transferred acute MBP-EAE [5]. In the early 
stages of chronic relapsing EAE active demyelination occurs in the CNS and PNS but later it 
is essentially restricted to the CNS and occurs in large plaques. This suggests that, in the later 
stages of active disease, the targeted myelin antigen is restricted to the CNS and therefore not 
MBP. Possible candidates for such a myelin antigen restricted to the CNS include PLP [18] 
and M2/myelin oligodendrocyte glycoprotein [3,4] M2 is a necessary antigen for the 
induction of chronic EAE in the guinea pig [2]. In all 4 forms of EAE in the Lewis rat, 
remyelination of the CNS by oligodendrocytes and of the PNS by Schwann cells occurs at the 
time of clinical recovery and is likely to be a major mechanism of this recovery. However, 
axonal degeneration occurs in EAE and is an important cause of residual neurological 
deficits. 
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